1. Home
  2. BBW vs LXRX Comparison

BBW vs LXRX Comparison

Compare BBW & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$37.45

Market Cap

629.9M

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.56

Market Cap

547.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
LXRX
Founded
1997
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
629.9M
547.4M
IPO Year
2004
2000

Fundamental Metrics

Financial Performance
Metric
BBW
LXRX
Price
$37.45
$1.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$67.71
$4.15
AVG Volume (30 Days)
526.1K
2.7M
Earning Date
03-12-2026
03-05-2026
Dividend Yield
2.50%
N/A
EPS Growth
4.11
77.78
EPS
2.73
N/A
Revenue
$357,866,000.00
$49,803,000.00
Revenue This Year
$5.71
N/A
Revenue Next Year
$4.12
N/A
P/E Ratio
$13.51
N/A
Revenue Growth
N/A
60.24
52 Week Low
$32.55
$0.36
52 Week High
$75.77
$1.83

Technical Indicators

Market Signals
Indicator
BBW
LXRX
Relative Strength Index (RSI) 29.84 48.13
Support Level N/A $1.47
Resistance Level $55.22 $1.65
Average True Range (ATR) 2.39 0.10
MACD 0.08 -0.02
Stochastic Oscillator 16.00 20.00

Price Performance

Historical Comparison
BBW
LXRX

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: